Detalhe da pesquisa
1.
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Future Oncol
; 18(12): 1449-1459, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040698
2.
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
N Engl J Med
; 373(5): 428-37, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222558
3.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25209003
4.
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer.
Invest New Drugs
; 31(1): 136-44, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22492020
5.
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors.
Invest New Drugs
; 31(3): 714-23, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054206
6.
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Clin Cancer Res
; 29(16): 3151-3161, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363966
7.
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mol Oncol
; 16(1): 104-115, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437759
8.
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia.
Clin Cancer Res
; 27(1): 60-69, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998965
9.
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
BMC Cancer
; 9: 263, 2009 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19643020
10.
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
J Clin Pharmacol
; 57(11): 1400-1408, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28561902
11.
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Clin Cancer Res
; 23(16): 4919-4928, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446508
12.
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Clin Ther
; 38(4): 778-93, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27041409
13.
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Rare Dis
; 2(1): e967148, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26942101
14.
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Nat Genet
; 46(5): 427-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658001
15.
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.
J Cancer
; 3: 58-66, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315651
16.
Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.
Expert Opin Investig Drugs
; 16(7): 1059-68, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17594189
17.
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
Anticancer Drugs
; 18(3): 283-9, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17264760
18.
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
J Clin Oncol
; 24(34): 5381-7, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17135639